BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budjan J, Attenberger UI, Schoenberg SO, Pietsch H, Jost G. The impact of injector-based contrast agent administration in time-resolved MRA. Eur Radiol 2018;28:2246-53. [PMID: 29218620 DOI: 10.1007/s00330-017-5178-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Davies J, Siebenhandl-Wolff P, Tranquart F, Jones P, Evans P. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Arch Toxicol 2022. [PMID: 34997254 DOI: 10.1007/s00204-021-03189-8] [Reference Citation Analysis]
2 Zhou Y, Zhu Y, Li J. Advantages of CT nano-contrast agent in tumor diagnosis: A retrospective study. Medicine (Baltimore) 2021;100:e27044. [PMID: 34664829 DOI: 10.1097/MD.0000000000027044] [Reference Citation Analysis]
3 Zanardo M, Sardanelli F, Rainford L, Monti CB, Murray JG, Secchi F, Cradock A. Technique and protocols for cardiothoracic time-resolved contrast-enhanced magnetic resonance angiography sequences: a systematic review. Clin Radiol 2021;76:156.e9-156.e18. [PMID: 33008622 DOI: 10.1016/j.crad.2020.08.028] [Reference Citation Analysis]
4 Sin D, McLennan G, Rengier F, Haddadin I, Heresi GA, Bartholomew JR, Fink MA, Thompson D, Partovi S. Acute pulmonary embolism multimodality imaging prior to endovascular therapy. Int J Cardiovasc Imaging 2021;37:343-58. [PMID: 32862293 DOI: 10.1007/s10554-020-01980-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Aziz M, Krishnam M, Madhuranthakam AJ, Rajiah P. Update on MR imaging of the pulmonary vasculature. Int J Cardiovasc Imaging 2019;35:1483-97. [PMID: 31030315 DOI: 10.1007/s10554-019-01603-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]